A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

June 28, 2012

Study Completion Date

December 20, 2012

Conditions
Respiratory Disorders
Interventions
PROCEDURE

Blood collection

Blood collection at Day 0 (all subjects) and at Month 6 (COPD subjects) for the analysis of serology, cell-mediated immune response.

PROCEDURE

Swab collection

Nasopharyngeal and oropharyngeal swabs collection at Day 0 (All subjects) and at exacerbation visits (COPD subjects).

PROCEDURE

Sputum collection

Sputum collection at Day 0 and at exacerbation visits (COPD subjects)

Trial Locations (3)

1000

GSK Investigational Site, Brussels

4000

GSK Investigational Site, Liège

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01516437 - A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD | Biotech Hunter | Biotech Hunter